Form 8-K - Current report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 22, 2024

BRADY CORPORATION

(Exact name of registrant as specified in its charter)

Commission File Number 1-14959


Wisconsin						39-0178960
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification No.)

6555 West Good Hope Road

Milwaukee, Wisconsin 53223

(Address of principal executive offices and Zip Code)

(414) 358-6600

(Registrant’s Telephone Number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share	BRC	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02			RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On February 22, 2024, Brady Corporation (the “Company”) issued a press release announcing its fiscal 2024 second quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.


Item 7.01			REGULATION FD DISCLOSURE

On February 22, 2024, the Company hosted a conference call related to its fiscal 2024 second quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Company’s website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.


Item 9.01			FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits


EXHIBIT NUMBER			DESCRIPTION
99.1			Press Release of Brady Corporation, dated February 22, 2024, relating to fiscal 2024 second quarter financial results.
99.2			Informational slides provided by Brady Corporation, dated February 22, 2024, relating to fiscal 2024 second quarter financial results.

104			Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


						BRADY CORPORATION

Date: February 22, 2024

						/s/ ANN E. THORNTON
						Ann E. Thornton
						Chief Financial Officer, Chief Accounting Officer and Treasurer

EXHIBIT 99.1

For More Information:

Investor contact: Ann Thornton 414-438-6887

Media contact: Kate Venne 414-358-5176

Brady Corporation Reports Fiscal 2024 Second Quarter Results and Raises the low end of its Fiscal 2024 Guidance

•Sales for the quarter decreased 1.1 percent. Organic sales increased 1.6 percent, foreign currency translation increased sales 0.8 percent and divestitures decreased sales 3.5 percent.

•Gross profit margin increased to 50.2 percent in the second quarter of fiscal 2024 compared to 48.0 percent in the second quarter of fiscal 2023.

•Diluted EPS increased 18.4 percent to $0.90 in the second quarter of fiscal 2024 compared to $0.76 in the same quarter of the prior year. Diluted EPS Excluding Certain Items* increased 14.8 percent to $0.93 in the second quarter of fiscal 2024 compared to $0.81 in the same quarter of the prior year.

•Net cash provided by operating activities increased to $36.1 million in the second quarter of fiscal 2024 compared to $29.4 million in the second quarter of last year.

•The low end of the Earnings per diluted Class A Common Share guidance was raised for the full year ending July 31, 2024 from the previous range of $3.70 to $3.95 to the new range of $3.80 to $3.95 on a GAAP basis, and was raised from the previous range of $3.85 to $4.10 to the new range of $3.95 to $4.10, excluding after-tax amortization expense.

MILWAUKEE (February 22, 2024) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2024 second quarter ended January 31, 2024.

Quarter Ended January 31, 2024 Financial Results:

Sales for the quarter ended January 31, 2024 decreased 1.1 percent, which consisted of organic sales growth of 1.6 percent, an increase of 0.8 percent from foreign currency translation, and a decrease of 3.5 percent from divestitures. Sales for the quarter ended January 31, 2024 were $322.6 million compared to $326.2 million in the same quarter last year. By region, sales decreased 3.8 percent in the Americas & Asia and sales increased 4.5 percent in Europe & Australia, which consisted of organic sales growth of 1.2 percent in the Americas & Asia and organic sales growth of 2.5 percent in Europe & Australia.

Income before income taxes increased 15.1 percent to $55.8 million for the quarter ended January 31, 2024, compared to $48.5 million in the same quarter last year. Income Before Income Taxes Excluding Certain Items* for the quarter ended January 31, 2024, which was adjusted for amortization expense of $2.4 million, was $58.2 million, an increase of 12.4 percent compared to the second quarter of last year.

Net income for the quarter ended January 31, 2024 was $43.6 million compared to $38.0 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share were $0.90 in the second quarter of fiscal 2024, compared to $0.76 in the same quarter last year. Net Income Excluding Certain Items* for the quarter

ended January 31, 2024 was $45.4 million and Diluted EPS Excluding Certain Items* for the quarter ended January 31, 2024 was $0.93. Net Income Excluding Certain Items* for the quarter ended January 31, 2023 was $40.5 million, and Diluted EPS Excluding Certain Items* for the quarter ended January 31, 2023 was $0.81.

Six-Month Period Ended January 31, 2024 Financial Results:

Sales for the six-month period ended January 31, 2024 increased 0.9 percent, which consisted of organic sales growth of 2.2 percent, an increase of 1.1 percent from foreign currency translation and a decrease of 2.4 percent from divestitures. Sales for the six months ended January 31, 2024 were $654.6 million compared to $648.8 million in the same period last year. By region, sales decreased 1.2 percent in the Americas & Asia and increased 5.3 percent in Europe & Australia, which consisted of organic sales growth of 2.3 percent in the Americas & Asia and organic sales growth of 2.0 percent in Europe & Australia.

Income before income taxes increased 16.6 percent to $115.2 million for the six-month period ended January 31, 2024, compared to $98.8 million in the same period last year. Income Before Income Taxes Excluding Certain Items* for the six months ended January 31, 2024, which was adjusted for amortization expense of $4.7 million, was $119.9 million, an increase of 13.4 percent compared to the same period of the prior year.

Net income for the six-month period ended January 31, 2024 was $90.9 million compared to $77.4 million in the same period last year. Earnings per diluted Class A Nonvoting Common Share were $1.86 for the six months ended January 31, 2024, compared to $1.55 in the same period last year. Net Income Excluding Certain Items* for the six months ended January 31, 2024 was $94.5 million and Diluted EPS Excluding Certain Items* for the six months ended January 31, 2024 was $1.94. Net Income Excluding Certain Items* for the six months ended January 31, 2023 was $82.7 million, and Diluted EPS Excluding Certain Items* for the six months ended January 31, 2023 was $1.65.

Commentary:

“We are delighted with the progress of our reorganization to a regional structure, which we announced in December of 2022. We are realizing operational savings while reinforcing our organization through our investments in R&D and sales and marketing initiatives. Even in this challenging manufacturing environment, we continue to grow with our Europe & Australia region performing particularly well,” said Brady’s President and Chief Executive Officer, Russell R. Shaller. “We believe our pipeline of new products will allow us to grow sales and profit as we integrate our businesses and execute our best go-to-market strategies in each geography. Our financial strength enables us to fund organic and inorganic growth initiatives to position ourselves for future success and increased shareholder value.”

“Brady is financially strong and we once again reported both organic sales growth and profit improvement. This quarter, we grew organic sales by 1.6 percent, we grew GAAP earnings per share by 18.4 percent, and cash flow from operating activities increased to $36.1 million from $29.4 million last year,” said Brady’s Chief Financial Officer, Ann Thornton. “Our capital expenditures increased to $60.8 million through January 31, 2024, which was primarily due to the purchase of a previously leased manufacturing facility. We are still in a net cash position of $95.8 million at January 31, 2024, which provides us with the flexibility to fully fund our organic growth investments, return funds to our shareholders in the form of dividends, and continue to be opportunistic with share buybacks and strategic acquisitions. We believe that our disciplined approach to capital allocation will continue to drive increased shareholder value over the long term.”

Fiscal 2024 Guidance:

The Company raised the low end of its GAAP earnings per diluted Class A Nonvoting Common Share guidance for the year ending July 31, 2024 from the previous guidance range of $3.70 to $3.95 per share to the new full year guidance range of $3.80 to $3.95 per share. The Company also raised the low end of its Diluted EPS Excluding Certain Items* guidance for the year ending July 31, 2024 from the previous range of $3.85 to $4.10 per share to the new full year guidance range of $3.95 to $4.10 per share.

The assumptions included in fiscal 2024 guidance include a full-year income tax rate of approximately 22 percent, depreciation and amortization expense ranging from $30 million to $32 million, and capital expenditures of approximately $75 million, which are inclusive of approximately $55 million related to the purchase of previously leased manufacturing facilities. Fiscal 2024 guidance is based on foreign currency exchange rates as of January 31, 2024 and assumes continued economic growth.

A webcast regarding Brady’s fiscal 2024 second quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2023, employed approximately 5,600 people in its worldwide businesses. Brady’s fiscal 2023 sales were approximately $1.33 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.

* Income Before Income Taxes Excluding Certain Items, Net Income Excluding Certain Items, and Diluted EPS Excluding Certain Items are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.

###

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; difficulties in protecting our websites, networks, and systems against security breaches; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; litigation, including product

liability claims; adverse impacts of regional epidemics or global pandemics; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; changes in tax legislation and tax rates; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2023.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited; Dollars in thousands, except per share data)


	Three months ended January 31,				Six months ended January 31,
	2024		2023		2024		2023
Net sales	$	322,624	$	326,249	$	654,607	$	648,818
Cost of goods sold	160,541		169,809		320,805		337,114
Gross margin	162,083		156,440		333,802		311,704
Operating expenses:
Research and development	16,832		15,377		32,534		29,310
Selling, general and administrative	91,325		92,282		187,612		182,227
Total operating expenses	108,157		107,659		220,146		211,537

Operating income	53,926		48,781		113,656		100,167

Other income (expense):
Investment and other income	2,684		968		3,122		811
Interest expense	(790)		(1,239)		(1,556)		(2,133)

Income before income taxes	55,820		48,510		115,222		98,845

Income tax expense	12,192		10,524		24,353		21,418

Net income	$	43,628	$	37,986	$	90,869	$	77,427

Net income per Class A Nonvoting Common Share:
Basic	$	0.90	$	0.76	$	1.88	$	1.55
Diluted	$	0.90	$	0.76	$	1.86	$	1.55

Net income per Class B Voting Common Share:
Basic	$	0.90	$	0.76	$	1.86	$	1.54
Diluted	$	0.90	$	0.76	$	1.85	$	1.53

Weighted average common shares outstanding:
Basic	48,374		49,745		48,440		49,806
Diluted	48,725		50,009		48,768		50,049

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)


	January 31, 2024		July 31, 2023
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	143,860	$	151,532
Accounts receivable, net of allowance for credit losses of $6,531 and $8,467, respectively	185,569		184,420
Inventories	164,944		177,078
Prepaid expenses and other current assets	12,147		11,790
Total current assets	506,520		524,820
Property, plant and equipment—net	190,777		142,149
Goodwill	590,535		592,646
Other intangible assets	57,108		62,096
Deferred income taxes	14,899		15,716
Operating lease assets	24,686		29,688
Other assets	23,079		22,142
Total	$	1,407,604	$	1,389,257
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	80,114	$	79,855
Accrued compensation and benefits	56,408		71,470
Taxes, other than income taxes	13,345		13,575
Accrued income taxes	8,228		12,582
Current operating lease liabilities	12,758		14,726
Other current liabilities	66,449		65,828
Total current liabilities	237,302		258,036
Long-term debt	48,090		49,716
Long-term operating lease liabilities	12,510		16,217
Other liabilities	70,970		74,369
Total liabilities	368,872		398,338
Stockholders’ equity:
Common stock:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 44,792,328 and 45,008,724 shares, respectively	513		513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35		35
Additional paid-in capital	353,794		351,771
Retained earnings	1,090,045		1,021,870
Treasury stock—6,469,159 and 6,252,763 shares, respectively of Class A nonvoting common stock, at cost	(305,714)		(290,209)
Accumulated other comprehensive loss	(99,941)		(93,061)
Total stockholders’ equity	1,038,732		990,919
Total	$	1,407,604	$	1,389,257

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)


	Six months ended January 31,
	2024		2023
Operating activities:
Net income	$	90,869	$	77,427
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,008		17,117
Stock-based compensation expense	5,263		4,381
Deferred income taxes	(3,640)		(5,234)
Other	947		(908)
Changes in operating assets and liabilities:
Accounts receivable	(5,030)		280
Inventories	10,078		(1,287)
Prepaid expenses and other assets	(1,187)		(3,502)
Accounts payable and accrued liabilities	(9,754)		(29,156)
Income taxes	(4,203)		(1,734)
Net cash provided by operating activities	98,351		57,384

Investing activities:
Purchases of property, plant and equipment	(60,832)		(8,167)
Other	—		11
Net cash used in investing activities	(60,832)		(8,156)

Financing activities:
Payment of dividends	(22,694)		(22,793)
Proceeds from exercise of stock options	5,366		2,688
Payments for employee taxes withheld from stock-based awards	(2,362)		(1,509)
Purchase of treasury stock	(21,797)		(17,861)
Proceeds from borrowing on credit agreement	69,145		71,036
Repayment of borrowing on credit agreement	(70,771)		(88,755)
Other	149		66
Net cash used in financing activities	(42,964)		(57,128)

Effect of exchange rate changes on cash	(2,227)		2,041

Net decrease in cash and cash equivalents	(7,672)		(5,859)
Cash and cash equivalents, beginning of period	151,532		114,069

Cash and cash equivalents, end of period	$	143,860	$	108,210

BRADY CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

(Unaudited; Dollars in thousands)


	Three months ended January 31,						Six months ended January 31,
	2024			2023			2024			2023
NET SALES
Americas & Asia	$	211,643		$	220,067		$	433,269		$	438,562
Europe & Australia	110,981			106,182			221,338			210,256
Total	$	322,624		$	326,249		$	654,607		$	648,818

SALES INFORMATION
Americas & Asia
Organic	1.2		%	6.9		%	2.3		%	5.4		%
Currency	0.1		%	(1.0)		%	—		%	(1.2)		%
Divestiture	(5.1)		%	—		%	(3.5)		%	—		%
Total	(3.8)		%	5.9		%	(1.2)		%	4.2		%
Europe & Australia
Organic	2.5		%	5.2		%	2.0		%	8.9		%
Currency	2.0		%	(8.9)		%	3.3		%	(12.8)		%
Total	4.5		%	(3.7)		%	5.3		%	(3.9)		%
Total Company
Organic	1.6		%	6.3		%	2.2		%	6.6		%
Currency	0.8		%	(3.7)		%	1.1		%	(5.1)		%
Divestiture	(3.5)		%	—		%	(2.4)		%	—		%
Total	(1.1)		%	2.6		%	0.9		%	1.5		%

SEGMENT PROFIT
Americas & Asia	$	43,895		$	40,174		$	93,792		$	81,319
Europe & Australia	15,054			13,459			31,798			30,217
Total segment profit	$	58,949		$	53,633		$	125,590		$	111,536
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia	20.7		%	18.3		%	21.6		%	18.5		%
Europe & Australia	13.6		%	12.7		%	14.4		%	14.4		%
Total	18.3		%	16.4		%	19.2		%	17.2		%


	Three months ended January 31,						Six months ended January 31,
	2024			2023			2024			2023
Total segment profit	$	58,949		$	53,633		$	125,590		$	111,536
Unallocated amounts:
Administrative costs	(5,023)			(4,852)			(11,934)			(11,369)
Investment and other income	2,684			968			3,122			811
Interest expense	(790)			(1,239)			(1,556)			(2,133)
Income before income taxes	$	55,820		$	48,510		$	115,222		$	98,845

GAAP to NON-GAAP MEASURES

(Unaudited; Dollars in Thousands, Except Per Share Amounts)

In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.

Income Before Income Taxes Excluding Certain Items:

Brady is presenting the non-GAAP measure, "Income Before Income Taxes Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Income Before Income Taxes Excluding Certain Items:


	Three months ended January 31,				Six months ended January 31,
	2024		2023		2024		2023
Income before income taxes (GAAP measure)	$	55,820	$	48,510	$	115,222	$	98,845
Amortization expense	2,364		3,258		4,719		6,889
Income Before Income Taxes Excluding Certain Items (non-GAAP measure)	$	58,184	$	51,768	$	119,941	$	105,734

Income Tax Expense Excluding Certain Items:

Brady is presenting the non-GAAP measure, "Income Tax Expense Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Income Tax Expense Excluding Certain Items:


	Three months ended January 31,				Six months ended January 31,
	2024		2023		2024		2023
Income tax expense (GAAP measure)	$	12,192	$	10,524	$	24,353	$	21,418
Amortization expense	548		769		1,094		1,634
Income Tax Expense Excluding Certain Items (non-GAAP measure)	$	12,740	$	11,293	$	25,447	$	23,052

Net Income Excluding Certain Items:

Brady is presenting the non-GAAP measure, "Net Income Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Net Income Excluding Certain Items:


	Three months ended January 31,				Six months ended January 31,
	2024		2023		2024		2023
Net income (GAAP measure)	$	43,628	$	37,986	$	90,869	$	77,427
Amortization expense	1,816		2,489		3,625		5,255
Net Income Excluding Certain Items (non-GAAP measure)	$	45,444	$	40,475	$	94,494	$	82,682

Diluted EPS Excluding Certain Items:

Brady is presenting the non-GAAP measure, "Diluted EPS Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Diluted EPS Excluding Certain Items (Note that certain amounts will not foot due to rounding):


	Three months ended January 31,				Six months ended January 31,
	2024		2023		2024		2023
Net income per Class A Nonvoting Common Share (GAAP measure)	$	0.90	$	0.76	$	1.86	$	1.55
Amortization expense	0.04		0.05		0.07		0.10
Diluted EPS Excluding Certain Items (non-GAAP measure)	$	0.93	$	0.81	$	1.94	$	1.65

Diluted EPS Excluding Certain Items Guidance:


	Fiscal 2024 Expectations
	Low		High
Earnings per Class A Nonvoting Common Share (GAAP measure)	$	3.80	$	3.95
Amortization expense	0.15		0.15
Diluted EPS Excluding Certain Items (non-GAAP measure)	$	3.95	$	4.10

F’24 Q2 Financial Results Brady Corporation February 22, 2024

Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as raw material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; difficulties in protecting our websites, networks and systems against security breaches; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; litigation, including product liability claims; adverse impacts of regional epidemics or global pandemics; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; changes in tax legislation and tax rates; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2023. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2

Q2 F’24 Highlights 3 * Diluted EPS Excluding Certain Items is a non-GAAP measure. See appendix. Organic sales grew 1.6%, with organic growth in both regions.Organic Sales Growth GPM of 50.2% compared to 48.0% in Q2 of F’23. Healthy gross profit margins demonstrate our high value-add.Improved GPM GAAP EPS of $0.90 was up 18.4% over Q2 of last year. Diluted EPS Excluding Certain Items* increased 14.8% to $0.93 in Q2 of F’24 compared to $0.81 in Q2 of F’23. Expanding Earnings per Share Americas & Asia organic sales growth of 1.2%; segment profit increased 9.3%. Europe & Australia organic sales growth of 2.5%; segment profit increased 11.9%. Regional Results Purchased 143k shares for $7.7M. Paid dividends of $11.4M. In a net cash position of $95.8M at January 31, 2024. Returning Capital to our Shareholders

Sales Overview 4 Q2 F’24 SALES: Total sales decreased 1.1%. Organic sales increased 1.6%. • Americas & Asia – Organic sales increased 1.2%. • Europe & Australia – Organic sales increased 2.5%. Foreign currency translation increased sales 0.8%. Divestitures decreased sales 3.5%. $277 $266 $296 $306 $321 $318 $339 $324 $323 $326 $337 $346 $332 $323 $225 $250 $275 $300 $325 $350 Q1 F'21 (4.9%) Q2 F'21 (6.3%) Q3 F'21 6.5% Q4 F'21 12.6% Q1 F'22 7.0% Q2 F'22 13.1% Q3 F'22 9.0% Q4 F'22 9.0% Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Organic Growth (Decline) SALES (millions of USD) Q2 F’24 SALES COMMENTARY: Organic sales were up 0.7% in the Americas with growth in all product lines except healthcare identification. Asia organic sales were up 5.1% with growth throughout the region. Organic sales were up 2.3% in Europe with growth in all major product lines. Australia organic sales were up 3.7%.

Gross Profit Margin 5 $135 $130 $149 $148 $155 $149 $164 $163 $155 $156 $170 $176 $172 $162 48.9% 48.7% 50.4% 48.2% 48.2% 47.0% 48.4% 50.4% 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 38% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 GROSS PROFIT & GPM% (millions of USD) Q2 F’24 – GROSS PROFIT MARGIN: Gross profit margin of 50.2% compared to 48.0% in Q2 of F’23. Improved product mix was the primary driver of the increase in gross profit margin in Q2 of F’24. Inflation continues, but we are experiencing a reduced rate of inflation in certain geographies.

SG&A Expense 6 Q2 F’24 – SG&A EXPENSE: SG&A expense was 28.3% of sales in both Q2 of F’24 and Q2 of F’23. Excluding amortization* from both periods, SG&A expense was 27.6% of sales compared to 27.3% of sales in the same quarter last year. Inflation continues in certain geographies. We continue to focus on executing sustainable efficiency gains in order to offset cost increases, while making the necessary investments to drive future sales growth. $83 $82 $91 $94 $97 $93 $96 $95 $90 $92 $91 $97 $96 $91 30.0% 30.9% 30.7% 30.6% 30.1% 29.1% 28.4% 29.2% 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 10% 15% 20% 25% 30% 35% $60 $70 $80 $90 $100 $110 $120 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD) * See appendix for non-GAAP measures.

R&D Expense 7 Q2 F’24 – R&D EXPENSE: We remain committed to our investments in R&D, our new product pipeline includes innovative products that solve problems for our customers. We are focused on ensuring that our R&D spend is both efficient and effective. $10.2 $9.9 $11.3 $13.2 $13.9 $14.0 $14.9 $15.8 $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 3.7% 3.7% 3.8% 4.3% 4.3% 4.4% 4.4% 4.9% 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 1.5% 2.5% 3.5% 4.5% 5.5% $8.0 $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)

Income Before Income Taxes 8 $42.2 $39.4 $47.8 $41.6 $44.7 $42.0 $51.3 $54.0 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $10 $20 $30 $40 $50 $60 $70 Q1 F'21 1.6% Q2 F'21 (7.0%) Q3 F'21 115.7% Q4 F'21 19.4% Q1 F'22 5.8% Q2 F'22 6.7% Q3 F'22 7.3% Q4 F'22 29.7% Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% * Income Before Income Taxes Excluding Certain Items is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q2 F’24 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes was up 15.1% to $55.8M in Q2 of F’24 compared to $48.5M in Q2 of F’23. Income Before Income Taxes Excluding Certain Items*, which only removes amortization expense from each period presented, increased 12.4% to $58.2M in Q2 of F’24 compared to $51.8M in Q2 of F’23. Year-on-Year Growth (Decline)

Net Income & Diluted EPS 9 Q2 F’24 – NET INCOME & DILUTED EPS: GAAP Net Income was $43.6M in Q2 of F’24 compared to $38.0M in Q2 of F’23 (an increase of 14.9%). • Net Income Excluding Certain Items* was $45.4M in Q2 of F’24 compared to $40.5M in Q2 of F’23 (an increase of 12.3%). GAAP Diluted EPS was $0.90 in Q2 of F’24 compared to $0.76 in Q2 of F’23 (an increase of 18.4%). • Diluted EPS Excluding Certain Items* was $0.93 in Q2 of F’24 compared to $0.81 in Q2 of F’23 (an increase of 14.8%). * Net Income Excluding Certain Items and Diluted EPS Excluding Certain Items are non-GAAP measures. See appendix. $33.5 $30.9 $37.3 $28.0 $35.0 $33.8 $40.1 $41.1 $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $20 $30 $40 $50 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 NET INCOME (GAAP) (millions of USD) $0.64 $0.59 $0.71 $0.53 $0.67 $0.65 $0.78 $0.81 $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $0.20 $0.40 $0.60 $0.80 $1.00 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 DILUTED EPS (GAAP)

Cash Generation 10 CASH FLOW FROM OPERATING ACTIVITIES $62.8 $36.1 $56.0 $50.8 $27.5 ($3.2) $40.9 $53.2 $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 -$5 $20 $45 $70 $95 Q1 F'21 188% Q2 F'21 117% Q3 F'21 150% Q4 F'21 181% Q1 F'22 78% Q2 F'22 (9%) Q3 F'22 102% Q4 F'22 130% Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83%% of Net Income CASH FLOWS IN Q2 OF F’24: Overview: Cash flow from operating activities was up 22.8% in Q2 of F’24; increasing from $29.4M in Q2 of last year to $36.1M in the current quarter. Free cash flow* was ($13.5M) in Q2 of F’24 compared to $25.1M in Q2 of F’23. Free cash flow was negative in Q2 of F’24 due to the purchase of a previously leased facility. Returning Funds to our Shareholders: In Q2 of F’24, we returned a total of $19.0M to our shareholders in the form of dividends and share buybacks. Dividends – Increased our annual dividend for the 38th consecutive year. Share Buybacks – Repurchased 143,115 shares in Q2 of F’24 for $7.7M (average price of $53.63/share). * Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Jan. 31, 2024 3 Mos. Ended Jan. 31, 2023 6 Mos. Ended Jan. 31, 2024 6 Mos. Ended Jan. 31, 2023 Cash Balance - Beginning of Period 175.4$ 114.5$ 151.5$ 114.1$ Cash Flow from Operating Activities 36.1 29.4 98.4 57.4 Capital Expenditures (49.6) (4.3) (60.8) (8.2) Dividends (11.4) (11.4) (22.7) (22.8) Share Repurchases (7.7) (5.8) (21.8) (17.9) Debt Repayments (4.1) (21.7) (1.6) (17.7) Effect of Exchange Rates on Cash 3.5 5.2 (2.2) 2.0 Other 1.7 2.3 3.1 1.3 Cash Balance - End of Period 143.9$ 108.2$ 143.9$ 108.2$

Net Cash 11 STRONG BALANCE SHEET: January 31, 2024 cash = $143.9M. January 31, 2024 debt = $48.1M. Balance sheet provides flexibility for future organic and inorganic investments. $256 $278 $322 $109 $91 $64 $26 $19 $15 $31 $84 $102 $123 $96 $0 $50 $100 $150 $200 $250 $300 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 NET CASH (millions of USD)

F’24 Diluted EPS Guidance GAAP Diluted EPS $3.80 to $3.95 (+8.3% to +12.5% vs. F’23) F’24 Diluted EPS, Excluding Certain Items* $3.95 to $4.10 (+8.5% to +12.6% vs. F’23) Guidance Assumptions: F’24 organic sales growth in the low-single digit percentages. The only difference between GAAP Diluted EPS and Diluted EPS, Excluding Certain Items* F’24 guidance is the impact of amortization expense of $0.15 per share. Full-year income tax rate of approximately 22%. Foreign currency exchange rates as of January 31, 2023. Depreciation and amortization expense of $30M to $32M. Capital expenditures of approximately $75M (inclusive of $55M related to the conversion of previously leased critical manufacturing facilities). 12 * Diluted EPS Excluding Certain Items is a non-GAAP measure. See appendix.

Americas & Asia 13 • Revenues decreased 3.8% in Q2 of F’24: • Organic growth = + 1.2%. • Fx increase = + 0.1%. • Divestiture = (5.1%). • Organic sales grew 0.7% in the Americas. Growth in wire identification, safety and facility identification, and product identification, decline in healthcare identification. • Organic sales grew 5.1% in Asia; growth throughout the region. • Segment profit increased due to organic sales growth in higher gross margin product lines. Q2 F’24 SUMMARY:Q2 F’24 vs. Q2 F’23 (millions of USD) $213 $208 $223 $218 $218 $220 $223 $227 $222 $212 18% 16% 20% 20% 19% 18% 22% 22% 23% 21% 0% 5% 10% 15% 20% 25% $100 $150 $200 $250 $300 Q1 F'22 9.3% 0.9% 8.3% Q2 F'22 13.9% - 8.1% Q3 F'22 9.2% (0.1%) 8.6% Q4 F'22 9.1% (1.0%) 2.8% Q1 F'23 4.0% (1.4%) - Q2 F'23 6.9% (1.0%) - Q3 F'23 1.2% (0.8%) (0.3%) Q4 F'23 5.6% (0.2%) (1.0%) Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) SALES & SEGMENT PROFIT % (millions of USD) Q2 F’24 Q2 F’23 Change Sales $ 211.6 $ 220.1 (3.8%) Segment Profit 43.9 40.2 + 9.3% Segment Profit % 20.7% 18.3% + 240 bps • Organic sales growth in the low-single digit percentages in F’24. • Continued growth in segment profit. OUTLOOK: Organic For. Curr. Acq. & Div.

Europe & Australia 14 • Revenues increased 4.5% in Q2 of F’24: • Organic growth = + 2.5%. • Fx increase = + 2.0%. • Organic sales grew 2.3% in Europe driven by growth in all major product lines. • Organic sales grew 3.7% in Australia due to increased volume and pricing. • Segment profit increased due to organic growth and operational efficiencies. Q2 F’24 SUMMARY:Q2 F’24 vs. Q2 F’23 (millions of USD) $109 $110 $116 $106 $104 $106 $114 $118 $110 $111 13% 15% 14% 16% 16% 13% 15% 16% 15% 14% 0% 5% 10% 15% $50 $75 $100 $125 $150 Q1 F'22 2.6% 0.6% 8.2% Q2 F'22 11.7% (5.8%) 9.6% Q3 F'22 8.5% (8.2%) 8.7% Q4 F'22 8.8% (13.9%) 1.8% Q1 F'23 12.8% (17.0%) - Q2 F'23 5.2% (8.9%) - Q3 F'23 3.4% (4.8%) - Q4 F'23 9.5% 2.0% - Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - SALES & SEGMENT PROFIT % Q2 F’24 Q2 F’23 Change Sales $ 111.0 $ 106.2 + 4.5% Segment Profit 15.1 13.5 + 11.9% Segment Profit % 13.6% 12.7% + 90 bps Organic For. Curr. Acquisitions • Organic sales growth in the low-single digit percentages in F’24. • Growth in segment profit. OUTLOOK: (millions of USD)

Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 15

Appendix GAAP to Non-GAAP Reconciliations

Non-GAAP Reconciliations 17 2024 2023 2024 2023 55,820$ 48,510$ 115,222$ 98,845$ Amortization expense 2,364 3,258 4,719 6,889 58,184$ 51,768$ 119,941$ 105,734$ 2024 2023 2024 2023 12,192$ 10,524$ 24,353$ 21,418$ Amortization expense 548 769 1,094 1,634 12,740$ 11,293$ 25,447$ 23,052$ Income before income taxes Income Before Income Taxes Excluding Certain Items (non-GAAP measure) Income Tax Expense Excluding Certain Items: Brady is presenting the non-GAAP measure, "Income Tax Expense Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Income Tax Expense Excluding Certain Items: Six months ended January 31, Income tax expense (GAAP measure) Six months ended January 31, GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Income Before Income Taxes Excluding Certain Items: Brady is presenting the non-GAAP measure, "Income Before Income Taxes Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Income Before Income Taxes Excluding Certain Items: Three months ended January 31, Three months ended January 31, Income Tax Expense Excluding Certain Items (non-GAAP measure)

Non-GAAP Reconciliations 18 2024 2023 2024 2023 43,628$ 37,986$ 90,869$ 77,427$ Amortization expense 1,816 2,489 3,625 5,255 45,444$ 40,475$ 94,494$ 82,682$ 2024 2023 2024 2023 $ 0.90 $ 0.76 $ 1.86 $ 1.55 Amortization expense 0.04 0.05 0.07 0.10 0.93$ 0.81$ 1.94$ 1.65$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $ 3.80 $ 3.95 Amortization expense 0.15 0.15 Diluted EPS Excluding Certain Items (non-GAAP measure) 3.95$ 4.10$ Three months ended January 31, Diluted EPS Excluding Certain Items: Brady is presenting the non-GAAP measure, "Diluted EPS Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Diluted EPS Excluding Certain Items (Note that certain amounts will not foot due to rounding): Six months ended January 31, Net income per Class A Nonvoting Common Share (GAAP measure) Net Income Excluding Certain Items (non-GAAP measure) Fiscal 2024 Expectations GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Diluted EPS Excluding Certain Items (non-GAAP measure) Three months ended January 31, Net Income Excluding Certain Items: Brady is presenting the non-GAAP measure, "Net Income Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Net Income Excluding Certain Items: Six months ended January 31, Net income (GAAP measure)

Document and Entity Information Document	Feb. 22, 2024
Document and Entity Information [Abstract]
Document Type	8-K
Entity Registrant Name	BRADY CORP
Amendment Flag	false
Document Period End Date	Feb. 22, 2024
Entity Central Index Key	0000746598
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity File Number	1-14959
Entity Tax Identification Number	39-0178960
Entity Incorporation, State or Country Code	WI
Entity Address, Address Line One	6555 West Good Hope Road
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53223
City Area Code	414
Local Phone Number	358-6600
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Class A Nonvoting Common Stock, par value $0.01 per share
Trading Symbol	BRC
Security Exchange Name	NYSE